Safety, antiviral activity, and pharmacokinetics of long-acting cabotegravir plus long-acting rilpivirine in virologically suppressed adolescents living with HIV-1 (IMPAACT 2017/MOCHA): week 96 and end-of-study results from a multinational, phase 1/2, single-arm trial
Publication date: December 2026 Source: The Lancet Child & Adolescent Health, Volume 10, Issue 12 Author(s): Carolyn Bolton Moore, Kristin Baltrusaitis, Edmund V Capparelli, Elizabeth D Lowenthal, Dwight E Yin, John H Moye, Christiana Smith, Michael Whitton, Conn M Harrington, Herta Crauwels, Rodica Van Solingen-Ristea, Mark A Marzinke, Barbara Heckman, Andi Ace, Shawn Ward, Kyle Whitson, Jenny Huang, S Y Amy Cheung, Brookie M Best, Ellen Townley
Safety, antiviral activity, and pharmacokinetics of long-acting cabotegravir plus long-acting rilpivirine in virologically suppressed adolescents living with HIV-1 (IMPAACT 2017/MOCHA): week 96 and end-of-study results from a multinational, phase 1/2, single-arm trial. // The Lancet Child & Adolescent Health. – URL: https://www.sciencedirect.com/science/article/pii/S235246422600221X?dgcid=rss_sd_all
Safety, antiviral activity, and pharmacokinetics of long-acting cabotegravir plus long-acting rilpivirine in virologically suppressed adolescents living with HIV-1 (IMPAACT 2017/MOCHA): week 96 and end-of-study results from a multinational, phase 1/2, single-arm trial. The Lancet Child & Adolescent Health. https://www.sciencedirect.com/science/article/pii/S235246422600221X?dgcid=rss_sd_all
“Safety, antiviral activity, and pharmacokinetics of long-acting cabotegravir plus long-acting rilpivirine in virologically suppressed adolescents living with HIV-1 (IMPAACT 2017/MOCHA): week 96 and end-of-study results from a multinational, phase 1/2, single-arm trial.” The Lancet Child & Adolescent Health.
@article{article68282,
title = {Safety, antiviral activity, and pharmacokinetics of long-acting cabotegravir plus long-acting rilpivirine in virologically suppressed adolescents living with HIV-1 (IMPAACT 2017/MOCHA): week 96 and end-of-study results from a multinational, phase 1/2, single-arm trial},
journal = {The Lancet Child \& Adolescent Health},
url = {https://www.sciencedirect.com/science/article/pii/S235246422600221X?dgcid=rss_sd_all}
}
ABSTRACT Aim To investigate the longitudinal association between early‐life movement behaviour patterns and later clinically diagnosed obesity. Method In the population‐based All Babies in Southeast Sweden (ABIS) cohort, 16 415 children...